EN

We strive to make patients-driven cellular immunotherapy innovation,
to transform cancer into a manageable condition — and ultimately cure it.


2019
  • 0
Streamlined Low-Input Transcriptomics through EASY-RNAseq.     
J Mol Biol. 431(24):5075-5085. (PMID: 31491452)
Zhou Y., Xu H., Wu H., Yu H., Zhou P., Qiu X., Zheng Z., Chen Q., Xu F., Li G., Zhou J., Cheng G., He W., Zou L, Wan Y. (2019) 

 TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis.  
EBioMedicine. (19)30474-8. (*: Corresponding authors, PMCID: PMC6796593)
Zheng M., Zhang X., Zhou Y., Tang J., Han Q., Zhang Y., Ni Q., Chen G., Jia Q., Yu H., Liu S., Robins E., Jiang NJ., Wan Y.*, Li Q.-J. *, Chen Z.-N.*, Zhu P.* (2019)
03.23
2022
Source:天科雅
Keysword:
Related Reading

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer